Novo Nordisk Inc.

NJ

UEI
W72BJMJYBMN3
CAGE
60554
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Foreign Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
800 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA
Website
novonordisk-us.com
Founded
1923
Employees
50K-100K
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Novo Nordisk Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Pharmaceuticals Contract · VA24113F0882 Veterans Integrated Service Network 1 $0
Novaseven RT Contract · VA69D12F0693 Veterans Integrated Service Network 12 $0
Medical, dental & veterinary eqip Contract · V614A10785 Veterans Integrated Service Network 9 $16,016
TAS::36 0160::TAS medical, dental & veterinary EQ Contract · V614A10283 Veterans Integrated Service Network 9 $11,477
Express report - ifcap to fpds-NG rejects novo seven injection Contract · V614A01413 Veterans Integrated Service Network 9 $38,256

About Novo Nordisk Inc.

Novo Nordisk Inc. is a global healthcare company specializing in diabetes care, as well as solutions for rare bleeding disorders, growth hormone related disorders, and obesity. The company provides pharmaceuticals and drugs to the federal government through various contract vehicles.

Novo Nordisk Inc. holds multiple Federal Supply Schedule contracts to provide pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule. These multiple award IDVs allow federal agencies to procure a variety of specialty medications related to diabetes, infections, hemophilia, and other conditions commonly impacting veterans. Additionally, Novo Nordisk has been awarded single-award indefinite delivery contracts from the VA and other agencies to supply human insulin and once-weekly glucagon injections. The IDVs have a total potential value exceeding $1.5 billion and provide treatment for diabetes, bleeding disorders, growth deficiency, and obesity-related illnesses. Task orders under the IDVs facilitate distribution of these drugs to VA hospitals and clinics, the Department of Defense, Bureau of Prisons, Indian Health Service, and other federal customers through 2025. The contract vehicles aim to leverage Novo Nordisk's manufacturing capabilities to ensure an uninterrupted, cost-effective supply of critical medications for federal health programs.

Contract vehicles

Quick answers

What is Novo Nordisk Inc.'s UEI?

Novo Nordisk Inc.'s Unique Entity ID (UEI) in SAM.gov is W72BJMJYBMN3.

What is Novo Nordisk Inc.'s CAGE code?

Novo Nordisk Inc.'s CAGE code is 60554.

What is Novo Nordisk Inc.'s primary NAICS code?

Novo Nordisk Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Novo Nordisk Inc. located?

Novo Nordisk Inc.'s physical address in SAM.gov is 800 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA.

Is Novo Nordisk Inc. registered in SAM.gov?

Yes. Novo Nordisk Inc.'s SAM.gov registration is active through September 17, 2027.

Which contract vehicles does Novo Nordisk Inc. hold?

Novo Nordisk Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Novo Nordisk Inc.'s most recent federal award?

Novo Nordisk Inc.'s most recent federal contract award is Pharmaceuticals (VA24113F0882), from Veterans Integrated Service Network 1, on May 2, 2013.

On GovTribe

See Novo Nordisk Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors